Outcomes of trigger finger corticosteroid injection with and without anesthetic

JRCT ID: jRCT1031230095

Registered date:26/05/2023

Basic Information

• Recruitment status: Recruiting
• Health condition(s) or Problem(s) studied: Trigger finger
• Date of first enrollment: 26/05/2023
• Target sample size: 60
• Study type: Interventional

Intervention(s)

We inject within the tendon sheath in two ways.
(1) Triamcinolone acetonide 0.1 ml (4 mg) + 1% mepivacaine 0.2 ml ( local anesthetic group) and
(2) Triamcinolone acetonide 0.1 ml (4 mg) + 0.2 ml of saline (saline group).

Outcome(s)

Primary Outcome

primary efficancy outcime: difference in pain VAS before and 1 month after injection
primary safety outcome:Frequency of numbness and adverse events (flexor tendon rupture, tendon sheath rupture, skin atrophy, skin leukoplakia, nerve damage, infection)

• Secondary Outcome: (1) pain VAS at the time of injection, (2) pain VAS at 10 minutes after injection, and (3) Quinnell classification.

Key inclusion & exclusion criteria

• Age minimum: >= 20age old
• Age maximum: Not applicable
• Gender: Both
• Include criteria: Trigger finger, Men and women over 20 years old, No history of injections in the affected finger
• Exclude criteria: Diabetic patients, patients with a history of trauma to the affected finger, patients with numbness in the affected finger, patients with symptoms in more than one finger on the affected side at the time of visit, and patients allergic to local anesthetics or steroids.

Related Information

• Primary Sponsor: Fukumoto Keizo
• Secondary ID(s): Nil known